CDMO Technology Domain
Bioavailability Engineering
Pharmacokinetic optimisation: nanoparticle systems, self-emulsifying drug delivery (SEDDS), liposomal encapsulation, cyclodextrin complexation, and BBB-penetrating carrier technologies.
24
dossiers
Intracellular Defense & IV-Alternatives
Bornaviruses: Genome Organization, Nuclear Replication, and Gene Expression Mechanisms
Developing effective antiviral therapies for nuclear-replicating RNA viruses like Bornaviruses requires deep understanding of their unique genomic organization and complex gene expression mechanisms, posing significant challenges for targeting viral replication without host toxicity.
Microvascular Hemodynamics & Endothelial Integrity
Topical Agents in Phlebology: Mechanisms, Efficacy, and Clinical Application Review
Developing stable, bioavailable topical formulations for venous diseases is challenging due to the need for deep tissue penetration and targeted action on microcirculation and inflammation while ensuring patient compliance.
Transmucosal Delivery & Dosage Form Engineering
Comparative Review of Topical Therapies for Atopic Dermatitis: Efficacy and Safety
Developing topical treatments for atopic dermatitis requires balancing potent anti-inflammatory efficacy with minimal local and systemic adverse effects, ensuring patient adherence, and optimizing transdermal delivery through a compromised skin barrier.
Microvascular Hemodynamics & Endothelial Integrity
Edestin's Health Benefits: Mechanistic Domains and Phlebology Applications
The primary challenge involves translating edestin's mechanistic benefits (antihypertensive, antioxidant, anti-inflammatory, endothelial effects) into proven clinical outcomes for phlebology, given current evidence gaps in venous disease trials. Optimizing processing and peptide delivery for enhanced bioavailability and targeted action in vascular health is critical.
Cellular Longevity & Senolytics
Clock Gene Expression (CLOCK/BMAL1) Impact on Pharmacokinetics: Implications for Chrononutrition and Chronopharmacology
Current pharmaceutical and nutritional guidelines often neglect circadian rhythmicity, leading to suboptimal therapeutic efficacy and unpredictable pharmacokinetic profiles for molecular interventions. Integrating clock gene biology into dosing regimens requires precise understanding of ADME variations.
Female Endocrine-Metabolic Crosstalk
Female Endocrine-Metabolic Axis: Formulation Technologies for Inositols and Antioxidants
Formulating stable, bioavailable, and patient-compliant products with precise inositol isomer ratios and sensitive antioxidants for female endocrine-metabolic health presents challenges in ingredient stability, dissolution, and avoiding paradoxical clinical effects from incorrect dosages.
Post-GLP-1 Metabolic Optimization
In Vivo Gene Editing via Lipid Nanoparticles: Base Editor Mechanisms and PCSK9 Targeting
Developing safe, durable, and highly targeted in vivo delivery systems for gene editing machinery (e.g., mRNA encoding base editors) to specific tissues like the liver via LNPs remains a significant challenge, requiring precise control over biodistribution and off-target effects.
Transmucosal Delivery & Dosage Form Engineering
Nutraceutical Pharmacokinetics: Advanced Delivery Systems for Improved Bioavailability
Many clinically relevant nutraceuticals exhibit poor oral bioavailability due to extensive first-pass metabolism and unfavorable physicochemical properties, making their therapeutic efficacy unpredictable in conventional forms.
Transmucosal Delivery & Dosage Form Engineering
Breakthroughs in Nutraceutical & Functional Food Technology: Delivery Systems, Green Manufacturing, and AI-Driven Precision Nutrition
Developing advanced nutraceuticals is challenged by low ingredient solubility, poor stability, and the lack of targeted or controlled release mechanisms, hindering optimal bioavailability and physiological efficacy. Ensuring robust evidence and regulatory acceptance for novel formulations further complicates development.
Post-GLP-1 Metabolic Optimization
Nutraceutical Toxicology and Herb-Drug Interactions (HDI/NDI): A Clinical Review of Six Critical Pharmacological Mechanisms
Developing safe and effective drug formulations requires comprehensive consideration of potential, often undisclosed, herb-drug interactions that can compromise efficacy or lead to life-threatening toxicities, especially with narrow therapeutic index compounds.
Intracellular Defense & IV-Alternatives
Personalized mRNA Neoantigen Vaccines: Efficacy and Safety in Melanoma and PDAC
Developing personalized mRNA neoantigen vaccines requires rapid, custom manufacturing workflows within a narrow therapeutic window, presenting significant logistical and scale-up complexities for widespread clinical adoption.
Precision Microbiome & Gut-Brain Axis
Pharmacomicrobiomics: Gut Microbiota Modulation of Drug Efficacy and Nutraceutical Biotransformation
Integrating the profound and variable metabolic capacity of the gut microbiome into pharmaceutical development to ensure consistent drug efficacy and bioavailability across diverse patient populations is a significant hurdle.
Transmucosal Delivery & Dosage Form Engineering
Piperine-Mediated Potentiation of Direct Oral Anticoagulants: A Clinically Unrecognized Hemorrhagic Risk
Piperine, marketed as a 'bio-enhancer' in nutraceuticals, dangerously potentiates DOACs by inhibiting P-gp and CYP3A4, leading to critical hemorrhagic risk due to uncontrolled increases in drug exposure. This unrecognized interaction demands safer alternatives for enhancing polyphenol bioavailability.
Transmucosal Delivery & Dosage Form Engineering
Innovations in Softgel Capsule Technology: Shell Materials, Lipid Formulations, and Stability Modeling
Developing advanced softgel formulations to overcome low water solubility and variable bioavailability of drug candidates, while addressing manufacturing, stability, and release challenges associated with novel plant-based shell materials.
Intracellular Defense & IV-Alternatives
De Novo Generative AI Drug Design: Clinical Progress and Methodological Landscape
Developing novel therapeutic molecules with high specificity and optimized pharmacological profiles rapidly, particularly for challenging targets, requires innovative and efficient design methodologies beyond traditional discovery pipelines.
Transmucosal Delivery & Dosage Form Engineering
Physicochemical Challenges in Alcohol-Free Sublingual Sprays: Solutions for Enhanced Stability and Bioavailability
Formulating stable alcohol-free sublingual sprays presents significant challenges, particularly for complex blends of amino acids and lipophilic botanicals, due to issues like crystallisation, phase separation, and subsequent nozzle obstruction.
Cellular Longevity & Senolytics
BCS Class IV Senolytics: Nano-Micellar Flavonoid Delivery for Targeted Senescence Clearance
Hydrophobic senolytic flavonoids like fisetin and quercetin face significant bioavailability challenges due to poor aqueous solubility, limiting their therapeutic potential. Conventional formulations fail to achieve adequate systemic exposure for effective cellular senescence clearance.
Intracellular Defense & IV-Alternatives
Isomeric Stabilization in High-Moisture Matrices: Protecting Fixed-Ratio Inositol Formulations
Fixed-ratio solid formulations are prone to segregation during manufacturing, especially under moisture-driven property changes, causing dose uniformity and accuracy challenges.
Intracellular Defense & IV-Alternatives
Intrapartum Bioenergetics: Rheological Engineering of a Carbohydrate-Based Hydrogel Matrix to Overcome Delayed Gastric Emptying During Active Labour
Developing a carbohydrate formulation for active labour is challenging due to delayed gastric emptying, high aspiration risk, and the need to prevent maternal and neonatal dysglycemia. Current oral options are inadequate, often necessitating IV administration.
Advanced BBB Permeability Solutions
Lipidic Nanoformulations for BBB Transport of Lipophilic Phytochemicals: Current Evidence and Challenges
Lipophilic phytochemicals exhibit poor systemic and brain bioavailability due to rapid metabolism, low solubility, and active efflux at the blood-brain barrier, impeding clinical translation.
Intracellular Defense & IV-Alternatives
Oxidative Stress Mitigation in Nutraceutical Stability: Packaging and Formulation Strategies
Nutraceutical dosage forms face significant degradation due to oxidative stress, driven by moisture, oxygen, and light. This presents a challenge for maintaining stability across supply-chain conditions and long shelf lives.
Intracellular Defense & IV-Alternatives
Non-Destructive Raman Spectroscopy for PAT-Based Botanical Contaminant Detection
Ensuring real-time quality control of botanical APIs is hindered by the need to detect trace contaminants, such as pesticide residues or adulterants, in heterogeneous botanical matrices while meeting regulatory sensitivity requirements.
Precision Microbiome & Gut-Brain Axis
Enteric Delivery of Butyrate: Overcoming Gastrointestinal Barriers for Vagal Activation
Free butyrate salts dissolve prematurely in the upper gastrointestinal tract, limiting their availability for distal gut signaling. Additionally, their pungent odor and taste present significant challenges for patient adherence in chronic applications.
Cellular Longevity & Senolytics
Comparative Pharmacokinetics and Cellular Bioaccessibility of Senolytic Agents: Impact of Polymeric-Matrix Encapsulation
Orally administered senolytic compounds often suffer from poor pharmacokinetics, including low and variable bioavailability, rapid metabolism, pH-dependent dissolution, and limited cellular bioaccessibility.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.